Related references
Note: Only part of the references are listed.CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2013-2017
Quinn T. Ostrom et al.
NEURO-ONCOLOGY (2020)
The Misclassification of Diffuse Gliomas: Rates and Outcomes
J. Bryan Iorgulescu et al.
CLINICAL CANCER RESEARCH (2019)
Impact of Timing of Adjuvant Chemoradiation for Glioblastoma in a Large Hospital Database
Virginia W. Osborn et al.
NEUROSURGERY (2018)
Newly diagnosed glioblastoma: adverse socioeconomic factors correlate with delay in radiotherapy initiation and worse overall survival
Erqi L. Pollom et al.
JOURNAL OF RADIATION RESEARCH (2018)
Effect of Tumor-Treating Fields Plus Maintenance Temozolomide vs Maintenance Temozolomide Alone on Survival in Patients With Glioblastoma A Randomized Clinical Trial
Roger Stupp et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)
Early initiation of chemoradiation following index craniotomy is associated with decreased survival in high-grade glioma
Jay K. Nathan et al.
JOURNAL OF NEURO-ONCOLOGY (2017)
Short-Course Radiation plus Temozolomide in Elderly Patients with Glioblastoma
James R. Perry et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
The influence of maximum safe resection of glioblastoma on survival in 1229 patients: Can we do better than gross-total resection?
Yan Michael Li et al.
JOURNAL OF NEUROSURGERY (2016)
Timing of Adjuvant Radiotherapy in Glioblastoma Patients: A Single-Institution Experience With More Than 400 Patients
Tony J. C. Wang et al.
NEUROSURGERY (2016)
Delaying standard combined chemoradiotherapy after surgical resection does not impact survival in newly diagnosed glioblastoma patients
Guillaume Louvel et al.
RADIOTHERAPY AND ONCOLOGY (2016)
Association of the Extent of Resection With Survival in Glioblastoma A Systematic Review and Meta-analysis
Timothy J. Brown et al.
JAMA ONCOLOGY (2016)
Survival impact of time to initiation of chemoradiotherapy after resection of newly diagnosed glioblastoma
Matthew Z. Sun et al.
JOURNAL OF NEUROSURGERY (2015)
The Effect of Timing of Concurrent Chemoradiation in Patients With Newly Diagnosed Glioblastoma
Seunggu J. Han et al.
NEUROSURGERY (2015)
Extent of Resection of Glioblastoma Revisited: Personalized Survival Modeling Facilitates More Accurate Survival Prediction and Supports a Maximum-Safe-Resection Approach to Surgery
Nicholas F. Marko et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Residual tumor volume versus extent of resection: predictors of survival after surgery for glioblastoma
Matthew M. Grabowski et al.
JOURNAL OF NEUROSURGERY (2014)
The combination of IDH1 mutations and MGMT methylation status predicts survival in glioblastoma better than either IDH1 or MGMT alone
Remco J. Molenaar et al.
NEURO-ONCOLOGY (2014)
A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma
Mark R. Gilbert et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Bevacizumab for Newly Diagnosed Glioblastoma Reply
Olivier L. Chinot et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
IDH Mutation in Glioma: New Insights and Promises for the Future
Zorbey Turkalp et al.
JAMA NEUROLOGY (2014)
Bevacizumab plus Radiotherapy-Temozolomide for Newly Diagnosed Glioblastoma
Olivier L. Chinot et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
MGMT Promoter Methylation and Glioblastoma Prognosis: A Systematic Review and Meta-analysis
Yang Chen et al.
ARCHIVES OF MEDICAL RESEARCH (2013)
Dose-Dense Temozolomide for Newly Diagnosed Glioblastoma: A Randomized Phase III Clinical Trial
Mark R. Gilbert et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2006-2010
Quinn T. Ostrom et al.
NEURO-ONCOLOGY (2013)
The impact of enrollment in clinical trials on survival of patients with glioblastoma
Tal Shahar et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2012)
The timing of cranial radiation in elderly patients with newly diagnosed glioblastoma multiforme
Rose Lai et al.
NEURO-ONCOLOGY (2010)
Oncological patterns of care and outcome for 952 patients with newly diagnosed glioblastoma in 2004
Luc Bauchet et al.
NEURO-ONCOLOGY (2010)
Short Delay in Initiation of Radiotherapy May Not Affect Outcome of Patients With Glioblastoma: A Secondary Analysis From the Radiation Therapy Oncology Group Database
Deborah T. Blumenthal et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
IDH1 and IDH2 Mutations in Gliomas
Hai Yan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Glioma extent of resection and its impact on patient outcome
Nader Sanai et al.
NEUROSURGERY (2008)
An integrated genomic analysis of human glioblastoma Multiforme
D. Williams Parsons et al.
SCIENCE (2008)
Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial
W Stummer et al.
LANCET ONCOLOGY (2006)
MGMT gene silencing and benefit from temozolomide in glioblastoma
ME Hegi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
R Stupp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Prognostic factors for survival of patients with glioblastoma: Recursive partitioning analysis
KR Lamborn et al.
NEURO-ONCOLOGY (2004)
Irradiation after surgically induced brain injury in the rat: timing in relation to severity of radiation damage
S Peker et al.
JOURNAL OF NEURO-ONCOLOGY (2004)
Revisiting the essential role of oxygen in wound healing
GM Gordillo et al.
AMERICAN JOURNAL OF SURGERY (2003)
A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival
M Lacroix et al.
JOURNAL OF NEUROSURGERY (2001)
Share Paper
